|
|
|
|
||
Re: Anyone have an estimated sales price to treat IgANI think it's reasonable to look at Omidria pricing as predictive of OMS721 pricing. Around $500. A high price until you consider the benefit to patients. It certainly will be interesting to see Omeros decision on OMS721 pricing. That pricing model will have a large impact on future revenues and mkt. cap. Just a guess but I'd say high 200K's low 300K's? |
return to message board, top of board |